FDA Adverse Event Malfunction Summary report: N

OMNIPOD DASH INSULIN MANAGEMENT SYSTEM

MDR report key: 12631391 · Received October 14, 2021

Report

Report Number
3004464228-2021-18408
Event Type
Malfunction
Date Received
October 14, 2021
Date of Event
October 11, 2021
Report Date
October 11, 2021
Manufacturer
INSULET CORPORATION
Product Code
LZG
UDI-DI
20385082000020
PMA / PMN Number
K192659
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

ACCORDING TO THE COMPLAINANT THE DEVICE WILL NOT BE RETURNED FOR INVESTIGATION. WE ARE UNABLE TO CONFIRM THE BENT CANNULA OR TO DETERMINE IF IT COULD HAVE CONTRIBUTED TO THE REPORTED HYPERGLYCEMIA. LOT RELEASE RECORDS WERE REVIEWED AND THE PRODUCT LOT MET ALL ACCEPTANCE CRITERIA. SPECIFICALLY, A POD IS PAIRED TO A PDM AND PUT THROUGH SIMULATED USE TESTING INCLUDING CONFIRMING THE BLUE SOFT CANNULA IS INSPECTED FOR ANY DAMAGE.

Description of Event or Problem · 1

IT WAS REPORTED THE PATIENT'S BLOOD GLUCOSE LEVEL ROSE TO 260 MG/DL WHILE WEARING THE POD LONGER THAN 48 HOURS. THE PATIENT EXPERIENCED PAIN AND WHEN REMOVED FROM THE INFUSION SITE (ABDOMEN), THE POD'S CANNULA WAS FOUND BENT. LIGHT BLEEDING AT THE SITE WAS ALSO REPORTED. AS TREATMENT, MORE INSULIN WAS GIVEN.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1534904 OMNIPOD DASH INSULIN MANAGEMENT SYSTEM PUMP, INFUSION, INSULIN LZG INSULET CORPORATION 18320 PD1C01302151 20385082000020

Patients

Seq Age Sex Outcome Treatment
1 76 YR